Public Company News
Pop Culture Group's Joint Venture to Receive Growth Investment from Nest Investment Management Co., Ltd.
XIAMEN, China, Dec. 12, 2022 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered inChina, today announced that the Company's joint venture, Shenzhen Jam Box Technology Co., Ltd ("JBT"), entered into an equity investme...
2022-12-12 22:00
4081
CARsgen Presents Data from China Pivotal Phase II Trial of BCMA CAR T Zevor-cel (CT053) at 2022 ASH Annual Meeting
SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thatat the 2022 American Society of Hematology (the "ASH") Annual Mee...
2022-12-12 21:50
3197
Yum China Achieves Highest Score in its Industry for the Third Consecutive Year on the Dow Jones Sustainability Index
Green power purchase program launched with two pilot restaurants SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) today announced that the Company was ranked the best in the 88 companies assessed in the Restaurant & Leisur...
2022-12-12 21:41
3955
Tantech Participated in Setting International Standards for Bamboo-based Activated Carbon
LISHUI, China, Dec. 12, 2022 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that its subsidiary, Zhejiang Tantech Bamboo Charcoal Co., Ltd., had received a certificate from the Bamboo and Rattan Technical Committee of the International Organizatio...
2022-12-12 21:30
3277
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)
DAEJEON, South Korea, Dec. 12, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company has entered into a clinical collaboration agreement with MSD (Merck & Co...
2022-12-12 21:00
3108
Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study
SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that Hexvix®, a drug used for bladder c...
2022-12-12 20:59
2417
Scienjoy Holding Corporation Reports Interim Nine months ended September 30, 2022 Unaudited Financial Results
Revenues up 21.2% Year Over Year Income from Operations up 15.3% Year Over Year BEIJING, Dec. 12, 2022 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "We") (NASDAQ: SJ), a leading live entertainment mobile streaming platform inChina, today announced its unaudited fin...
2022-12-12 20:00
4040
China Automotive Systems Launches New Electric Power Steering Systems for BYD
WUHAN, China, Dec. 12, 2022 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that it has introduced a new series of Electric Power Steering ("EPS") systems for the largest Ch...
2022-12-12 19:00
3304
JinkoSolar's High-efficiency N-Type Monocrystalline Silicon Solar Cell Sets Our New Record with Maximum Conversion Efficiency of 26.4%
SHANGRAO, China, Dec. 12, 2022 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it has achieved a major technical breakthrough for its 182 mm high-efficien...
2022-12-12 18:16
2775
Asieris Enrolled First Patient for its Phase II Clinical Study of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer
SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the first patient enrolled in phas...
2022-12-12 17:47
2324
Acer Listed on Dow Jones Sustainability Indices (DJSI) 2022; Achieves Its Highest Ranking in Nine Years
Recognized among industry leaders in the THQ Computers & Peripherals and Office Electronics category at No. 2 TAIPEI, Dec. 12, 2022 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced that it has been listed on the Dow Jones Sustainability Indices (DJSI) Emerging Markets Index in 2022 for the ninth...
2022-12-12 14:33
2967
JITC publication of Akeso's Ligufalimab(CD47 monoclonal antibody) mechanism shows promising antitumor efficacy and favorable safety profile
HONG KONG, Dec. 11, 2022 /PRNewswire/ -- Akeso Inc. (9926. HK) ("Akeso") today announced that the Journal for Immunotherapy of Cancer (JITC), a BMJ oncology journal, published the mechanism of action of its Ligufalimab (AK117).The article's name is "Ligufalimab, a novel anti-CD47 antibody with no...
2022-12-12 12:59
2802
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery
CHENGDU, China, Dec. 11, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. ("Nitrase"), a biopharmaceutical company deploying its NITROME platform to buil...
2022-12-12 10:10
2870
Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk, Newly Diagnosed Multiple Myeloma Demonstrating 100% Overall Response Rate
BCMA/CD19 dual-targeting FasTCAR-T GC012F data from ongoing clinical trial presented at 64th American Society of Hematology Annual Meeting and Exposition SAN DIEGO and SUZHOU and SHANGHAI, China, Dec. 10, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL)...
2022-12-11 07:15
4590
Sentage Holdings Inc. Announces Financial Results for the First Six Months of Fiscal Year 2022
SHANGHAI, Dec. 9, 2022 /PRNewswire/ -- Sentage Holdings Inc. (the "Company", "we", "our") (Nasdaq: SNTG), is a holding company incorporated in theCayman Islands with no material operations of its own. Through its China-based operating entities, the Company offers a comprehensive range of financia...
2022-12-10 05:15
7737
ReneSola Power Announces Results of Annual General Meeting
STAMFORD, Conn., Dec. 9, 2022 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power" or the "Company") (www.renesolapower.com <>) (NYSE: SOL), a leading fully-integrated solar projectdeveloper, today announced the results of its 2022 annual general meeting of shareholders. Specifically, the Company's ann...
2022-12-10 05:01
7438
iQIYI Launches World's First Virtual Reality Game Show Memoon Player
BEIJING, Dec. 9, 2022 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service inChina, released the virtual reality (VR) variety game showMemoon Player with the first episode airing on Dec. 9. An iQIYI original production,Memoon Player invites viewers to join the show par...
2022-12-09 19:04
4136
ChipMOS REPORTS NOVEMBER 2022 REVENUE
HSINCHU, Dec. 9, 2022 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC.
("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150
2022-12-09 19:00
4297
Acer Reports November Consolidated Revenues at NT$ 18.91 Billion, Up 4.7% Month-on-month
TAIPEI, Dec. 9, 2022 /PRNewswire/ -- Acer Inc. (TWSE: 2353) reports its November consolidated revenues atNT$18.91 billion, up 4.7% month-on-month. Its year-to-November revenues reachedNT$252.54 billion, down 12.7% year-on-year (YoY). Businesses other than PCs and displays contributed 26.6% of No...
2022-12-09 17:24
4137
ATRenew Announces Extension of its Existing Share Repurchase Program
SHANGHAI, Dec. 9, 2022 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced that its board of directors has authorized an extension of the Company's existing ...
2022-12-09 17:00
3753
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Nuix Neo Generative AI Framework
[Picked up by 260 media titles]
2026-10-08 08:02Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
11651
LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results
2026-10-08 09:50
9222
XPENG G9L Completes First Production Trial in Europe
2026-10-08 07:33
8880
